Skip to main content
. 2020 Sep;12(9):4950–4959. doi: 10.21037/jtd.2020.02.50

Table 1. TB incidence rates in cancer patients stratified by cancer type.

Type of cancer Cancer patients, N (%) Cancer patients with TB IR of TB in cancer patients/100,000 person-year
BCTB CDTB All TB BCTB CDTB All TB
Malignant brain tumor (including eye, spinal cord) 474 (1.36) 3 0 3 436 436
Head and neck cancera 994 (2.86) 18 4 22 921 202 1,126
Lung cancer 3,454 (9.93) 78 38 116 1,886 907 2,804
Esophageal cancer 446 (1.28) 16 3 19 2,798 520 3,323
Stomach cancer 6,120 (17.59) 75 18 93 575 137 713
Colorectal cancer 4,145 (11.92) 37 17 54 407 186 594
Hepatobiliary/pancreatic cancer
     Hepatocellular carcinoma 3,496 (10.05) 25 11 36 468 205 674
     Biliary tract cancer 1,073 (3.08) 6 1 7 397 66 463
     Pancreatic cancer 907 (2.61) 13 1 14 1,724 131 1,857
Hematologic cancer
     Lymphoma 756 (2.17) 14 1 15 849 60 909
     Leukemia 576 (1.66) 14 1 15 1,515 107 1,623
     Multiple myeloma 208 (0.60) 10 0 10 2,649 2,649
Thyroid cancer 4,824 (13.87) 19 6 25 145 46 191
Breast cancer 3,216 (9.25) 12 8 20 144 96 240
Uterine and ovary cancer
     Cervical cancer 1,031 (2.96) 10 1 11 415 41 457
     Uterine cancer 302 (0.87) 2 0 2 278 278
     Ovary cancer 527 (1.52) 6 1 7 533 88 622
Urological cancer
     Kidney cancer 603 (1.73) 8 1 9 516 64 580
     Ureter and bladder cancer 838 (2.41) 4 4 8 215 215 430
     Prostate cancer 793 (2.28) 10 0 10 551 - 551
Total 34,783 (100.0) 380 116 496 535 163 699

a, malignancy above chest except brain, eye, and thyroid. BCTB, bacteriologically confirmed tuberculosis; CDTB, clinically diagnosed tuberculosis; IR, incidence rate; IRR, incidence rate ratio; TB, tuberculosis.